Home
Conditions
TDP-43 Proteinopathies

Clinical trial condition

TDP-43 Proteinopathies

Explore clinical trials studying TDP-43 Proteinopathies. Study availability and eligibility vary by location and protocol.

870 public trials 211 recruiting studies

Refine in advanced search Browse all conditions

TDP-43 Proteinopathies trial results

Completed

Autologous Multipotent Mesenchymal Stromal Cells in the Treatment of Amyotrophic Lateral Sclerosis

NCT03828123

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +9 more
Locations: Not specified

View Trial Details

Completed

Phase II/III Randomized, Placebo-controlled Trial of Arimoclomol in SOD1 Positive Familial Amyotrophic Lateral Sclerosis

NCT00706147

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: University of Miami Miller School of Medicine Miami, Florida, United States

Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Autologous Cultured Mesenchymal Bone Marrow Stromal Cells Secreting Neurotrophic Factors (MSC-NTF), in ALS Patients.

NCT01051882

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +11 more
Locations: Hadassah Medical Organization Jerusalem, Israel

View Trial Details

Completed

Exploratory Study of Biotelemetry in Amyotrophic Lateral Sclerosis

NCT02447952

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: GSK Investigational Site London, United Kingdom

GSK Investigational Site Oxford, United Kingdom

View Trial Details

Completed

ALS Reversals - Lunasin Regimen

NCT02709330

Conditions: ALS (Amyotrophic Lateral Sclerosis), Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, +9 more
Locations: Duke Medicine / Neurology Durham, North Carolina, United States

View Trial Details

Completed

Brain and Nerve Stimulation for Hand Muscles in Spinal Cord Injury and ALS

NCT02469675

Conditions: Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +13 more
Locations: James J. Peters VA Medical Center, Bronx, NY The Bronx, New York, United States

View Trial Details

Completed

Laughter Therapy Effects on Mood, Stress and Self-efficacy in People With Neurological Diseases.

NCT02750982

Conditions: Alzheimer Disease, Alzheimer's Disease, Amyotrophic Lateral Sclerosis, +46 more
Locations: Evergreen Healthcare Kirkland, Washington, United States

View Trial Details

Completed

Trial of Ascertaining Individual Preferences for Loved One's Role in End-of-Life

NCT01160367

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Digestive System Diseases, +20 more
Locations: Johns Hopkins University Baltimore, Maryland, United States

View Trial Details

Completed

Impact of Emotional Mimicry and Oxytocin on Frontotemporal Dementia

NCT01937013

Conditions: Brain Diseases, Central Nervous System Diseases, Dementia, +10 more
Locations: Parkwood Hospital London, Ontario, Canada

View Trial Details

Completed

Effect of Motor Rehabilitation Treatment on Amyotrophic Lateral Sclerosis (ALS)

NCT02306109

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: Department of Neuroscience, S. Anna Hospital Ferrara, Italy

Department of Neuroscience, S.Agostino-Estense Hospital Modena, Italy

Department of Neuroscience, IRCCS Arcispedale Santa Maria Nuova Reggio Emilia, Italy

View Trial Details

TDP-43 Proteinopathies

TDP-43 Proteinopathies trial results

Related conditions